Glioblastoma trials in Australia

In Australia 19 Also abroad 424

19 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
A First-in-Human Study of ZE94-0605 in Patients With Advanced Solid Tumors
Where
Bedford Park, Kogarah
Age
18 years and over
People
60 worldwide
Run by
Eilean Therapeutics
See details and how to joinNCT07524140
Phase 2/3Taking people
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Where
Bedford Park, Heidelberg, Herston, Melbourne, St Leonards, Waratah
Age
18 years and over
People
2,250 worldwide
Run by
Global Coalition for Adaptive Research
See details and how to joinNCT03970447 · EU 2024-511452-40-00
Early phase 1Not yet taking people in Australia
Biomarker-guided RAdiation-deferring Treatment in Younger GBM Patients - Pilot Study
Where
Heidelberg
Age
18 years to 55 years
People
12
Run by
Olivia Newton-John Cancer Research Institute
See details and how to joinNCT07908147
Phase 1/2Taking people
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Where
Camperdown, Concord, Epping, Waratah
Age
18 years and over
People
450 worldwide
Run by
Bayer
See details and how to joinNCT06914128 · EU 2025-520623-24-00
Phase 1Not yet taking people in Australia
OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed Glioblastoma
Where
Brisbane, Heidelberg, Herston, Melbourne, Sydney
Age
18 years to 75 years
People
54
Run by
Olivia Newton-John Cancer Research Institute
See details and how to joinNCT07739017
Phase 3Taking people
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Where
Darlinghurst, Herston, Melbourne, Nedlands, Saint Leonards
Age
18 years and over
People
365 worldwide
Run by
Nuvation Bio Inc.
See details and how to joinNCT05303519
Phase 1/2Taking people
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Where
Nedlands, Randwick, South Brisbane, Westmead
Age
Up to 25 years
People
75 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00
Phase 2Taking people
Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
Where
Parkville
Age
18 years and over
People
92 worldwide
Run by
Duke University
See details and how to joinNCT06816927
Phase 1Taking people
Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
Where
Liverpool, Randwick
Age
18 years to 100 years
People
26
Run by
Charlotte Lemech
See details and how to joinNCT06132438
No phaseTaking people
Targeted Pediatric High-Grade Glioma Therapy
Where
Melbourne, Perth, Randwick, South Brisbane
Age
12 months to 39 years
People
350 worldwide
Run by
Nationwide Children's Hospital
See details and how to joinNCT05839379
Phase 2Taking people
Study of Olutasidenib and Temozolomide in HGG
Where
Perth, Randwick, South Brisbane
Age
12 years to 39 years
People
60 worldwide
Run by
Rigel Pharmaceuticals
See details and how to joinNCT06161974
No phaseTaking people
The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab
Where
Saint Leonards
Age
18 years and over
People
20
Run by
Royal North Shore Hospital
See details and how to joinNCT07052877
Phase 3Taking people
Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma
Where
Adelaide, Gold Coast, Melbourne, Perth
Age
18 years and over
People
50 worldwide
Run by
Telix Pharmaceuticals (Innovations) Pty Limited
See details and how to joinNCT07100730
Early phase 1Not yet taking people in Australia
Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma
Where
Melbourne
Age
18 years and over
People
12
Run by
Olivia Newton-John Cancer Research Institute
See details and how to joinNCT07712770
Early phase 1Taking people
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Where
Perth, Randwick, South Brisbane
Age
1 year to 21 years
People
15 worldwide
Run by
Nationwide Children's Hospital
See details and how to joinNCT06333899
Phase 2Taking people
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Where
Melbourne, Perth, Randwick, South Brisbane
Age
12 months to 39 years
People
120 worldwide
Run by
Nationwide Children's Hospital
See details and how to joinNCT05843253
No phaseTaking people
MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy
Where
St Leonards
Age
18 years and over
People
20
Run by
University of Sydney
See details and how to joinNCT05500612
Phase 1/2Taking people
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
Where
Kogarah, Liverpool, Miranda
Age
18 years and over
People
80
Run by
Filamon LTD
See details and how to joinNCT06926075
Phase 2Taking people
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Where
Melbourne
Age
18 years and over
People
497 worldwide
Run by
Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00